XC268BG

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameXC268BG
Drug Alias NameXC-268BG
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsMetabolic Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPharmenterprises Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmenterprises Llc
Active IndicationsN/A
Inactive IndicationsMetabolic Syndrome

Other Information

ATC CodeN/A
Related LinksN/A